Lichen planus associated with omalizumab administration in an adult with allergic asthma

Annals of Allergy, Asthma and Immunology

Volumn 102, Issue 4, 2009, Pages 349-351

  Seeborg, Filiz O ^a   Rihal, Pardeep S ^b   Czelusta, Adam ^c   Sanchez, Ramon ^c   Hanson, Imelda C ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b West Houston Allergy and Asthma PA   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; BECLOMETASONE; CETIRIZINE; CROMOGLYCATE DISODIUM; DICLOFENAC; ESOMEPRAZOLE; FLUTICASONE; HYDROCHLOROTHIAZIDE; IMMUNOGLOBULIN E; LISINOPRIL; MONTELUKAST; OMALIZUMAB; SALBUTAMOL;

ADULT; ALLERGIC ASTHMA; ANAMNESIS; CASE REPORT; CD4 CD8 RATIO; CLINICAL FEATURE; DIARRHEA; DISEASE DURATION; DRUG ERUPTION; DRUG WITHDRAWAL; EPISTAXIS; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; INJECTION SITE REACTION; LABORATORY TEST; LETTER; LICHEN PLANUS; MENORRHAGIA; NAUSEA; PRESCRIPTION; PRIORITY JOURNAL; PUNCH BIOPSY; RECOMMENDED DRUG DOSE; RECURRENT DISEASE; SKIN ANAPHYLAXIS; VOMITING;

EID: 65249158485     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60343-2     Document Type: Letter

References (16)

1. Genentech Inc. Prescription information: summary of product characteristics. http://www.xolair.com. Accessed December 9, 2008.
2. Katta R. Lichen planus. Am Fam Physician. 2000;11:3319-3324.
3. Boyd AS, Neldner KH. Lichen planus. J Am Acad Dermatol. 1991;25:593-619.
4. Pilli M, Penna A, Zerbini A, et al. Oral lichen planus pathogenesis: a role for the HCV-specific cellular immune response. Hematology. 2002;36:1446-1452.
5. Al-Khenaizan S. Lichen planus occurring after hepatitis B vaccination: a new case. J Am Acad Dermatol. 2001;45:614-615.
6. Ellgehausen P, Elsner P, Burg G. Drug-induced lichen planus. Clin Dermatol. 1998;16:325-332.
7. Pfab F, Athanasiadis GI, KollmarA, Ring J, Ollert M. Lichenoid drug eruption due to an antihypertonic drug containing irbesartan and hydrochlorothiazide. Allergy. 2006;61:786-787.
8. Pascual JC, Matarredona J, Miralles J. Oral and cutaneous lichenoid reaction secondary to imatinib: report of two cases. Int J Dermatol. 2006;45:1471-1473.
9. Bovenschen HJ, Seyger MMB, Van De Kerkhof PCM. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation. Br J Dermatol. 2005;153:72-78.
10. Porter SR, Kirby A, Olsen I, Barrett W. Immunologic aspects of dermal and oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;83:358-366.
11. Breathnach SM. Mechanisms of drug eruptions: part I. Australas J Dermatol. 1995;36:121-127.
12. Halevy S, Shai A. Lichenoid drug eruptions. J Am Acad Dermatol. 1993;29:249-255.
13. Chipps B. Systemic reaction to omalizumab. Ann Allergy Asthma Immunol. 2006;97:267.
14. Food and Drug Administration, Centers for Biologics Evaluation and Research. Review of Clinical Safety Data. Washington, DC: Department of Health and Human Services; 2003. BLA STN 103976/0.
15. Patel GK, Turner RJ, Marks R. Cutaneous lichen planus and squamous cell carcinoma. J Eur Acad Dermatol Venereol. 2003;17:98-100.
16. Poole JA, Matangkasombut P, Rosenwasser LJ. Targeting the IgE molecule in allergic and asthmatic diseases: review of the IgE molecule and clinical efficacy. J Allergy Clin Immunol. 2005;114:S375-S385.